窑Review窑
In recent years, significant efforts have been devoted to develop nanotechnology to enhance the delivery of anticancer drug to tumor tissue while minimizing its distribution and toxicity in healthy tissue. Many developed innovative nanotechnology platforms, such as polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles, and nucleic acidbased nanoparticles [DNA, RNA interference (RNAi) , and antisense oligonucleotide (ASO)], have been applied to the delivery of specific anticancer drugs, including small molecular weight drugs and macromolecules (proteins, peptides or genes). The physicochemical characteristics of nanotechnology platforms, such as composition, particle size, surface charge, surface functionalization with hydrophilic polymers, and inclusion of tissuerecognition ligands, will conduct their biodistribution and pharmacokinetics [1] . Hereby, the nanotechnology platforms could serve as customizable, targeted drug delivery vehicles capable of carrying large dose of therapeutic agents into malignant cells while avoiding healthy cells. This article overviewed current nanotechnologies for cancer therapy, focusing on the wide variety of nanotechnological platforms for anticancer drug delivery and nanotechnologies for combination therapeutic strategies.
The most common examples of nanotechnology platforms for cancer therapy include polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, and superparamagnetic nanoparticles. With small size and various structural and physicochemical features, these nanotechnology platforms can enter tumor vasculature through enhanced permeability and retention effect (EPR). The use of cancerspecific targeting residues (e.g. antibodies, ligands, and lectins) can also achieve tumor cell targeting.
Polymeric nanoparticles are prepared from natural or synthesized polymers. Various biodegradable or unbiodegradable polymers can be used to prepare nanoparticles in order to achieve expected drug delivery performance and therapeutic effect. Among these, biodegradable polymeric nanoparticles for anticancer drug delivery have attracted great interest in recent years since they could provide controlled, sustained and targeted delivery. Polymeric nanoparticles, the most effective nanotechnology platforms, have emerged as a versatile carrier system for targeted delivery of anticancer drugs [2, 3] . Bernardi . [4] investigated the effect of indomethacin loaded nanocapsules on a xenograft glioma model in rats. The rats presented a significant reduction in tumor size and half of them presented just residual tumor cells; moreover, the animal survival rate was much larger in the drugloaded nanocapsule group than in the control (untreated), indomethacin and drugunloaded nanocapsule groups [4] . Polymeric nanoparticles can deliver not only small molecular weight drugs but also macromolecules such as genes and proteins. A system made up of poly (D, Llactidecoglycolide) nanoparticles, a potent protease inhibitor (cystatin) and cytokeratinspecific monoclonal antibody, has been reported. It can neutralize the activity of excessive proteolysis in order to prevent the metastatic and invasive potential of breast tumor cells [5] . To stabilize the surface of nanoparticle or achieve active targeting, conjugating, grafting and adsorbing hydrophilic polymers, such as polyethylene glycol (PEG), are usually used. Copolymer pegylation and folate conjugation can improve the stability of selfassemblies in aqueous medium and the tumor site selectivity in vivo of ringopening metathesis polymerizationbased copolymers [6] . By covalent coupling of humanized monoclonal antibodies (antiHER2) to paclitaxelloaded poly (D, Llactic acid) nanoparticles, immunonanoparticles were prepared to actively target tumor cells which overexpress HER2 receptors [7] . Recently, Patil .
[8] produced PLAPEGligand conjugate nanoparticles by a singlestep surface functionalizing technique, and found that simultaneous functionalization with biotin and folic acid induced great efficacy of paclitaxelloaded nanoparticles in a MCF7 tumor xenograft model by enhancing drug accumulation in tumors.
Mitoxantroneloaded polybutylcyanacrylate nanoparticles (DHADPBCANPs) have presented a good effect on orthotopically transplanted hepatocellular carcinoma (HCC) in nude mice. Therefore, the activity and toxicity of DHADPBCANPs in individuals with unresected HCC were evaluated in a phase II clinical trial [9] . The median survival was much longer in the DHADPBCANPs group than in the DHAD injection group (5.46 months vs. 3.23 months) [9] . Polymeric nanoparticles are currently the most widely investigated nanotechnology platform for cancer therapy, despite many challenging defects or drawbacks need to be resolved before clinical application. It is also considered as the most promising vehicle for sitetargeting anticancer drug delivery and disease diagnosis because of its good variability of chemical structures through chemical modification and the resulting flexibility of physicochemical characteristics enabling its diverse drug delivery applications.
As closed spherical vesicles, liposomes consist of a lipid bilayer which encapsulates an aqueous phase to store drugs [10] . With the size (90150 nm) which is slightly bigger than the conventional definition (臆100 nm), liposomes do not constitute novel nanotechnology, but a large portion of them are associated with nanotechnology research [11] . Forming lipid bilayers through hydrophobic interaction, liposomes are considered as excellent platforms for the delivery of hydrophobic and hydrophilic drugs. In particular, liposomes present considerable persistence in the blood. It facilitates efficient drug delivery to target tissues. Different lipids have different fatty acid chain lengths, different head groups, and different melting temperatures. Consequently, temperature [12] or pH sensitive [1315] liposomes can be constructed by manipulating the formulation. The effectiveness of 1methylxanthine (1MTX) as a radiosensitizer and the in vivo efficacy of the temperaturesensitive liposomal 1methylxanthine (tslMTX) which combined with regional hyperthermia and ionizing radiation were evaluated [12] . Intraperitoneal injection of the tslMTX inhibited tumor growth in the mouse xenograft tumor model; moreover, the combination of tslMTX with regional hyperthermia and ionizing radiation obviously inhibited tumor growth [12] . Most recently, to target leukemic cells, pHsensitive immunoliposomes (ILs) including a terminally alkylated Nisopropylacrylamide (NIPAM) in the bilayer were coupled with the antiCD33 monoclonal antibody [15] . The pHsensitive ILsCD33 immunoliposomes exhibited high cytotoxicity against HL60 cells, suggesting that the pHsensitive immunoliposomes could be profitable in acute myeloid leukemia therapy.
Commercial liposomes have already gained approval from US Food and Drug Administration (FDA). The typical example is doxorubicinencapsulated liposomes (Doxil), which has strong antitumor activity against a wide range of cancers.
As highly branched artificial macromolecules with treelike structures, dendrimers are monodisperse, threedimensional molecules which have defined molecular weights and hosteguest entrapment properties [16] . With the www.cjcsysu.cn size ranging from 1 to 10 nm, dendrimers with different chemical structures and functional groups can be synthesized. Through a series of repeating chemical synthesis on the core, the size and shape of dendrimers are determined by the generation. The key useful character of dendrimers is the branches which can provide vast amounts of surface area for drugs and targeting molecules [11, 17] . Meanwhile, the surface functionalities, interior branching, and chemical composition of the core play a significant role in reactiviting the macromolecule [17] . Dendrimer is one of the most elegant nanotechnology platforms for targeted drug delivery. Conjugated with biotin as the targeting moiety, the in vitro targeting ability of partially acetylated generation 5 polyamidoamine (PAMAM) dendrimer (AcG5) in HeLa cells was assessed [18] . The multifunctional conjugate AcG5biotinFITC (fluoresceinisothiocyanate) showed much higher cellular uptake than the conjugate without biotin. The energydependent uptake process can be blocked effectively by biotinpolymer conjugates, exhibiting an expected doseresponse curve.
As the layerbylayer assembly of nanoparticles, polymeric nanoshells (2060 nm) of diblock copolymers can be made by selfassembly of oppositely charged polymers forming a core/shell structure [19] . With a biodegradable polymer core and mixed lipid monolayer shell, a system of folic acidconjugated nanoparticles was developed for targeted delivery of docetaxel [20] . Gold nanoshells (10 to 300 nm) are optically tunable nanoparticles comprising a dielectric core with a thin gold shell surrounded [21] . In order to achieving maximal penetration of light through tissue over the nearinfrared, gold nanoshells can be designed by adjusting the core radius and the shell thickness [21] . Laseractivated gold nanoshells thermal ablation is a selective and effective technique for the ablation of prostate cancer in an ectopic tumor model [22] .
As a distinct molecular form of carbon atoms which bond with each other via sp 2 bonds and present a hexagonal arrangement, carbon nanotubes were first discovered in the late 1980s [11, 23] . Conceptually, carbon nanotubes are described as wellordered, hollow nanotubes formed when single or multiple graphene sheets are rolled into a cylinder [23, 24] . The two forms of carbon nanotubes are single and multiwalled carbon nanotubes. In the family of nanotechnology platforms, carbon nanotubes have been identified as a novel tool for anticancer drug delivery [25] . Apart from that, carbon nanotubes can immobilize molecules, such as antibodies, DNA and drugs [2628] , in order to penetrate cell membranes. Heister . [26] have used an oxidized singlewalled carbon nanotube, consisting of a fluorescent marker and a monoclonal antibody at noncompeting binding sites, to delivery anticancer drug doxorubicin. However, because of the needlelike fiber shape, the safety of carbon nanotubes is concerned. Recently, the biological impacts (cytotoxicity, DNA damage, and inflammation) induced by differentsized multiwalled and singlewalled carbon nanotubes, have been studied [29] . The results demonstrate that long and thick multiwalled carbon nanotubes probably induce severe biological effects and may cause the augmentation of cancer risk.
Superparamagnetic nanoparticles, iron oxide magnetic nanoparticles with particle sizes of about 20 nm, are composed of Fe 2 O 3 or Fe 3 O 4 and do not keep any magnetism after removal of the magnetic field, hence, may be used in vivo [30] . Superparamagnetic nanoparticles can be used as contrast agents for magnetic resonance imaging (MRI), can be used for cancer thermal therapy, and can concentrate in target sites through an external magnetic field. Functionalized with recombinant single chain Fv antibody fragments (scFv), superparamagnetic iron oxide nanoparticles (SPIONs) could be used to target and image cancer cells [31] . Conjugated to luteinizing hormone releasing hormone (LHRH), SPIONs not only achieve breast cancer cell targeting but also play the role as contrast agents in the MRI of breast cancer xenografts [32] . The postmortem neuropathologic studies of glioblastoma multiforme (GBM) patients treated with thermotherapy using magnetic nanoparticles were reported [33] . Magnetic nanoparticles were injected into the tumor and then heated in an alternating magnetic field. The instillation of magnetic nanoparticles in GBM patients induced the uptake of nanoparticles in macrophages to a major extent, and the uptake was further promoted by magnetic fluid hyperthermia (MFH) therapy [33] .
Gene therapy refers to the direct transfer and expression of DNA into diseased cells for the therapeutic applications [34] . Veiseh . [35] have developed a ligand mediated nanovector by binding the chlorotoxin (CTX) peptide and pegylation of DNAcomplexing polyethylenimine (PEI) in nanoparticles which functionalized with an Alexa Fluor 647 near infrared fluorophore . Mixed nanoparticles, prepared with generations 4 and 5 poly (amidoamine) (PAMAM) dendrimers and plasmid DNA, were confirmed to be effective for both in vitro and in vivo gene delivery to colon and liver cancer cells [36] . Based on oligonucleotides, RNAi and ASO ther apies can shut down the expression of target genes to treat the disease [19] . Recently, siRNA nanoparticles were first designed with Poly (Propyleneimine) (PPI) dendrimers [37] .
The resistance to chemotherapy is a substantial clinical problem limiting the effectiveness of anticancer drug treatment. Because of microenvironmental selection pressures, tumor cells can generate multidrug resistance (MDR). MDR of cancer cells refers to resilience against functionally and structurally unrelated drugs [38] . The mechanisms of MDR include sequestration, increased drug efflux, decreased drug influx, binding site modification, activation of detoxifying enzymes, blocked apoptotic signaling, and DNA repair [39] . In order to overcome MDR, the nanotechnology for combination therapeutics has attracted increasing attention in these years. Drug delivery combined with various modulations (e.g. modulation of drug efflux, apoptotic threshold, and intracellular pH) and energy therapies (e.g. ultrasound, hyperthermia, and photodynamic therapy) have shown significant promise in enhancing MDR cancer therapy.
Combining chemotherapeutic agent with MDR modulator is a common solution for overcoming MDR in cancer therapy. Overexpression of ATPbinding cassette (ABC) transporters which are involved in drug efflux, is a key factor in cancer MDR [40] . Among various ABC transporters, Pglycoprotein (Pgp/MDR1/ABCB1) is commonly expressed in drugresistant cells. Tariquidar, one of the third generation Pgp inhibitors, has shown marked effectiveness in early clinical trials. Patil . [41] have investigated overcoming MDR by targeted delivery of paclitaxel, using tariquidar as the Pgp modulator and poly (D,Llactidecoglycolide) nanoparticles as the platform which were functionalized with biotin on the surface. The accumulation of paclitaxel in drugresistant tumor cells resulted in enhanced therapeutic efficacy of the nanoparticles [41] . After treatment with biotinfunctionalized nanoparticles which loaded both paclitaxel and tariquidar (the paclitaxel dose was ineffective without tariquidar), the growth of drugresistant tumor in mice was significantly inhibited [41] . Several other ABC transporters also contribute to MRD, such as multidrug resistanceassociated protein (ABCC1/MRP1) and breast cancer resistance protein (ABCG2/BCRP) [40, 42, 43] . However, nonABC transporters were also studied to develop combination therapeutics for the modulation of drug efflux. One approach is the use of Cdc2. RLIP76, a nonABC, stressresponsive drug transporter, conjugates glutathioneelectrophileconjugate (GSE), which is overexpressed in various cancers. As a cell cycle check point control kinase, Cdc2 can bind to RLIP76 during mitosis and inhibit endocytosis [44] . Liposomal Cdc2 delivery to H358 cells induced apoptosis, increased intracellular accumulation of doxorubicin, and decreased drug efflux from the cells [44] . The marked obstructing effect of liposomal Cdc2 delivery on drug efflux indicates a big potential for a novel MDR cancer therapy by combining chemotherapeutic agent with Cdc2.
For MDR cancers, a high apoptotic threshold can be caused by increased expression of antiapoptotic factors or inhibition of proapoptotic factors. Survivin, a member of inhibitor of apoptosis protein (IAP) family, is overexpressed in MDR cancer cells. Codelivery of docetaxel and iSurpDNA, a suppressor of survivin, showed combined effect of anticancer drug and gene therapy [45] . A folatemodified multifunctional nanoassembly (FNA) was manufactured and used for the research of human HCC [45] . Compared with free docetaxel and FNAs loading only iSurpDNA, FNAs loading both docetaxel and iSurpDNA presented much higher cytotoxicity to HCC cells both in vitro and in vivo [45] . The main challenge of gene therapy is the effective delivery. Combining targeted delivery of anticancer drug with the modulation of apoptotic threshold, FNAs is an efficient strategy for overcoming MDR.
As one of the distinguishing characteristics of MDR cells, decreased intracellular pH can be exploited to design nanoparticulate delivery. In order to improve the therapeutic efficacy of doxorubicin (DOX) on MDR cancers, two polymeric nanoconjugates were developed and micelles based on the conjugates were decorated with 琢 v茁 3 integrin targeting ligand (RGD4C) for active cancer targeting [46] . Using the pHsensitive hydrazone bonds , DOX was conjugated to the degradable poly (ethylene oxide)blockpoly (3 caprolactone) (PEObPCL) core in the first formulation, which named RGD4CPEObP (CLHydDOX); the second formulation, named RGD4CPEObP (CLAmiDOX), was obtained by conjugating DOX to the core using the more stable amide bonds [46] . Based on AFM and DLS, both two block copolymerDOX conjugates selfassembled into spherical nanoparticles (60 to 90 nm) [46] . Both micelles did not release detectable DOX levels at physiological pH of 7.2, but the release significantly increased at pH 5.0 [46] . In vitro studies showed that both micelles decorated with RGD4C can effectively increase the therapeutic efficacy of DOX on human MDA435/LCC6 MDR cancer [46] . The active targeting of pHsensitive carriers may further decrease the cytotoxicity to normal cells, thereby conferring a benefit on the treatment of aggressive MDR cancers.
Ultrasound is used in many medical applications, www.cjcsysu.cn especially cancer therapy. Recently, the ability of ultrasound to induce controlled release of tumorlocalized drugs from nanotechnology platforms has been studied. Schroeder . [47] exposed Stealth cisplatin to low frequency ultrasound (LFUS) (3.3 W/cm 2 ) for different periods of time (30180 s) to induce a timedependent release, and achieved a release amount of 62% after 180 s of LFUS irradiation. Then, the ability of LFUS to improve the anticancer efficacy of cisplatinloaded nano sterically stabilized liposomes (nSSL) was studied [48] . In J6456 murine lymphoma tumors that exposed to LFUS, about 70% of cisplatin was release, which was much larger than those not exposed to LFUS (< 3% ) [48] . The therapeutic efficacy of LFUSinduced localized cisplatin release was studied on BALB/c mice bearing C26 colon adenocarcinoma [48] . Compared with other groups, the group treated by cisplatinloaded nSSL combined with LFUS had the best therapeutic effect that tumors not only stopped proliferating but also regressed over time [48] . Using ultrasound to enhance the drug release of targeting carriers is probably a viable technique for MDR cancer therapy.
Many studies on overcoming MDR also focus on combing drug delivery with hyperthermia. Combining hyperthermia with folate receptortargeted thermosensitive magnetic liposomes loaded with doxorubicin (MagFolDox) was described [49] . At 42.5益 and 43.5益 , magnetic hyperthermia significantly increased the tumor cytotoxicity of MagFolDox [49] . It indicates that a system of physical and biological drugtargeted delivery combined with hyperthermia can be used advantageously for cancer therapy.
Photodynamic therapy (PDT) is a therapeutic modality used in cancer treatment. Combination of drug delivery and PDT has been used to target MDR cancer cells. Khdair . [50] have studied the effect of doxorubicin nanoparticles in combination with PDT on MDR cancer in a mouse tumor model. Surfactantpolymer hybrid nanoparticles, which composed of AerosolOT TM (AOT) and sodium alginate, were used for synchronized delivery of doxorubicin and methylene blue [50] . With Balb/c mice bearing mammary adenocarcinoma as a MDR tumor model, the combination therapy significantly enhanced drug accumulation and inhibited tumor proliferation [50] . Combining PDT with drugloaded nanoparticles may be a promising technique to overcome MDR in cancer therapy.
Nanotechnology has many advantages in cancer therapy. With small size, nanotechnology platforms can enter tumor vasculature via EPR. Besides, functionalization with hydrophilic polymer/oligomer can offer a long circulation halflife and prolong the exposure time of tumor tissue to anticancer agents; whereas inclusion of tissuerecognition residues, such as antibodies, lectins and ligands which are specific for cancer cells, can help nanotechnology platforms achieve tumor cell targeting. For overcoming MDR of cancer cells, a major challenge in effective cancer therapy, combinations of multifunctional nanotechnology platforms and other therapies have been developed and achieved significant successes. However, there are still challenges to the development and application of nanotechnology platforms in cancer therapy, such as limited knowledge of the cancer cell physiology, small variety and poor functionalization of medical nanomaterials, and deficiency of clinical evaluation criteria. Nonetheless, with further advances in functionalization base on thorough understanding of the physiological features of cancer cells, nanotechnology platforms hold the promise of essentially changing the practice of oncology, allowing easy and effective targeted therapies.
